In patients with comorbid anxiety and depression, minocycline showed a trend toward reducing anxiety symptoms without significantly affecting depression scores in individuals primarily diagnosed with Major Depressive Disorder, with effects persisting post-treatment [ 450 ].
← all excerpts
From Stress to Substance Use Disorders: The Expanding Role of Microglia-Astrocyte Crosstalk in Neuroimmune and Glutamate Alterations in the Nucleus Accumbens.
1
—
—